Laser zaps prostate tumors without major surgery

NCT ID NCT07339943

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a new, less invasive way to treat intermediate-risk prostate cancer using a laser guided by micro-ultrasound. The goal is to see if the procedure is safe and can delay or avoid the need for more aggressive treatments like surgery or radiation. Seven men aged 40-80 with early-stage prostate cancer will be enrolled and followed for 6 months.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
laser ablation (heat therapy delivered via a diode laser system)
What this could lead to
If successful, this could offer a less invasive option for men with intermediate-risk prostate cancer, potentially delaying or avoiding the need for surgery or radiation.
What could go wrong
This is a very early, small study with only 7 participants, so results may not apply to everyone. The procedure may not fully eliminate the cancer or could cause side effects like pain or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOW AND INTERMEDIATE RISK PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Health Network - Princess Margaret Cancer Centre

    RECRUITING

    Toronto, Ontario, M5G 2M9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.